25 LLC’s Dynavax Technologies DVAX Stock Holding History

25 LLC’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-46	Closed	-$645	–	179
2023 Q2	$645	Buy	+46	New	+$524	﹤0.01%	354

Other funds holding DVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

25 LLC's DVAX Position: Q3 2023 in Review

25 LLC sold out of Dynavax Technologies (DVAX) in Q3 2023, closing a stake of 46 shares — an estimated $645 sold.

25 LLC first reported a position in DVAX in Q2 2023 and held it in 1 quarter. The position peaked at $645 in Q2 2023. 225 funds tracked by Wall St. Rank hold DVAX as of Q3 2023.

25 LLC reported no remaining Dynavax Technologies position as of Q3 2023 after selling out during the quarter.
25 LLC sold 46 Dynavax Technologies shares in Q3 2023, an estimated $645.
25 LLC first reported a position in Dynavax Technologies in Q2 2023 and held it in 1 quarter.
25 LLC's Dynavax Technologies position peaked at $645 in Q2 2023.
225 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.